<DOC>
	<DOC>NCT00873821</DOC>
	<brief_summary>A study to test the pharmacokinetics after twice daily administration of MK-0941 or placebo in subjects with type 2 diabetes who have inadequate control on metformin.</brief_summary>
	<brief_title>A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Subject has a BMI &lt; 42 kg/m2 Subject is taking &gt;1500 mg metformin per day for at least 8 weeks Subject has HbA1c value of 7.0% and &lt; 11% at screening Subject is willing to follow AHA weight maintaining diet and exercise program Subject is a nonsmoker for at least 6 months Subject has type 1 diabetes Subject has a history of stroke or chronic seizure Subject has a history of neoplastic disease Subject has a history of gastrointestinal, cardiovascular, blood, liver kidney, respiratory, immunological or genitourinary disorders or diseases Subject is currently taking 2 or more diabetes medications Subject has glaucoma or is blind If female, subject is pregnant or breastfeeding Subject consumes &gt; 3 alcoholic beverages per day Subject has had major surgery or has donated blood in the last 4 weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>